United States Allergy Prescription Pharmaceutical Markets

 

USD 3,950

* Required Fields

USD 3,950

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Allergy Prescription Pharmaceutical Markets, Executive SummaryIntroduction to the Allergy Prescription Pharmaceutical MarketsIntroduction to the Allergy Prescription Pharmaceutical MarketsAllergies—A DefinitionSummary of Major FindingsMarket Growth, Opportunities, and ForecastAnalysis by Major SegmentCompetitive Analysis ConclusionsConclusionsUnited States Allergy Prescription Pharmaceutical Markets, Market Engineering Research MethodologyResearch ScopeObjectives and PurposeReport Structure and Market SegmentationMarket Engineering Forecasting MethodologyOverviewStrategic Significance of the Market Engineering ForecastJudging Credibility and Accuracy of Market Engineering ForecastsForecast AssumptionsUnited States Allergy Prescription Pharmaceutical Markets, Industry ChallengesIdentification of Challenges Facing the U.S. Allergy Prescription Pharmaceutical MarketsIdentification of Challenges Facing the U.S. Allergy Prescription Pharmaceutical MarketsPossible Changes in Health Care Coverage Limit RevenuesEducating Patients Regarding Allergy Treatment Options Lowers Confusion and Stimulates Demand for More Effective DrugsMaking Allergy Management a Priority Within the United States Is Vital to the Success of Prescription Allergy Medications Prioritizing Importance and Seriousness of Allergies Improves Awareness of Prescription Allergy Drug Medications Emphasizing the General Practitioners Role Within Allergy Management Increases Understanding of Disease and Boosts RevenuesDifferentiating Allergy Medications from One Another Essential to Product’s SuccessClearly Stating Benefits and Limitations of New Allergy Medications Increase Success and Reduce Public BacklashLack of Understanding over What Is and What Is Not an Allergy Confuses Patients Converting Allergy Sufferers from OTC to Prescription Drug UsersMarket Engineering Research for the U.S. Antihistamine Prescription Market 1996-2006Market Overview Market Overview AntihistaminesMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversNew Second Generation Antihistamines Improve Quality of Allergy MedicationsChronicity of Symptoms Coupled with New Patients Every Year, Guarantees Large Population Base for Medications Patent Extensions Consolidate Market Leaders Dominance of the Marketplace and Helps Shering-Plough Retain Its Dominance of the Antihistamine MarketClinical Efficacy and Economics of Competitive Products Promote Market Growth Through CompetitionLine Extensions of Antihistamines Tap Extra Sources of RevenueIntroduction of Desloratadine Improves Ability of Claritin to Retain Market Share LeadNew Liquid Formulations Increase Demand from Pediatric Segment of the PopulationDosing Improvements of Antihistamines Help Meet Needs of MarketNew Antihistamines Gain from Withdrawal of Seldane and Hismanal from the MarketLarge Amounts of Direct to Consumer (DTC) Spending Stimulates Sales of Anithistamine MedicationsNew Antihistamine Spray Provides Ease of Use to More UsersMarket RestraintsMarket RestraintsEntrance of Generic Competition for Market LeaderHigh Cost of Second-Generation Drugs Limits Market AcceptanceMinimal Product Differentiationin a Mature Market Limits Market Share for New Products Generic Forms of Loratadine Threaten Claritin’s Dominance of the Allergy MarketplaceMultiple Prescription to Over the Counter Switches Detrimental to Prescription Allergy MarketIncreasing Popularity of Immunotherapy Treatments Reduces Need for AntihistaminesMarket Engineering Revenue Forecasts (1996-2006)Market Engineering Revenue Forecasts (1996-2006)Assumptions in the Market ModelMarket Share ForecastsOther Market and Technology TrendsAntihistamines for ConjunctivitisNew DevelopmentsCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyProduct AnalysisMarket Engineering Research for the U.S. Corticosteroid Prescription Market 1995-2006Market Overview Market Overview Nasal/Inhaled CorticosteroidsTopical CorticosteroidsGlucocorticoidsMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversIntroduction of New, More Effective Corticosteroids Stimulates MarketNew Corticosteroids Efficacy Within Pediatric Market Increases SalesCorticosteroid Treatment for Perennial Allergic Rhinitis Provides Advantage over AntihistaminesNasal Corticosteroids Decongestant Ability Decreases Use of Antihistamine-Decongestant CombinationsCheaper Price of Corticosteroid Treatment Relativeto Antihistamines Offers Huge Advantage to Growth of Market Heavy Advertising Increases Awareness and Expands Sales of Corticosteroid MarketMarket RestraintsMarket RestraintsGranting Nasalcrom OTC Status Takes Away Corticosteroid Market ShareNegative Perception of Corticosteroids Limits Use Relative to AntihistaminesConfusion over the Proper Dosing Administration Increases Frustration And Reduces Use of CorticosteroidsPerception That Corticosteroids Only Intended to Treat Asthma Reduces Revenue Increased Popularity of Immunotherapy Treatments Reduces Demand for CorticosteroidsMarket Engineering Revenue Forecasts (1996-2006)Market Engineering Revenue Forecasts (1996-2006)Trends by End UserPricing Strategy and Market Share Trend AnalysisCompetitive StructureCompetitive StructureCompetitive Market Share Analysis: Winners, Losers, and WhyMarket Share Trends Emerging TrendsUnited States Allergy Prescription Pharmaceutical Markets, End-User Survey—Assessing Allergy Management Within the United StatesIntroductionIntroductionAbout Immune.comStudy ObjectivesSurvey ResultsSurvey ResultsAllergy Medication DataLevel of Satisfaction with Allergy ManagementCost of TreatmentSummaryMarket Engineering Awards for the Allergy Prescription Pharmaceutical MarketsFrost & Sullivan's 2000 Market Engineering AwardsFrost & Sullivan's 2000 Market Engineering AwardsMarket Engineering AwardsMarket Engineering AwardsAward Category: Marketing Strategy Award Category: Product Innovation Award Category: Product Line Strategy




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.